Medpace Holdings, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2015 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Medpace Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2015 to Q3 2024.
Medpace Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $22.4M, a 76.7% increase year-over-year.
Medpace Holdings, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $67.1M, a 47.6% increase year-over-year.
Medpace Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was $52.9M, a 41% increase from 2022.
Medpace Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was $37.5M, a 87.4% increase from 2021.
Medpace Holdings, Inc. annual Income Tax Expense (Benefit) for 2021 was $20M, a 13.6% decline from 2020.

Income Tax Expense (Benefit), Trailing 12 Months (USD)

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$67.1M	$22.4M	+$9.7M	+76.7%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-10-22
Q2 2024	$57.4M	$22.1M	+$7.46M	+50.8%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-07-23
Q1 2024	$49.9M	$10.2M	-$2.95M	-22.4%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-04-23
Q4 2023	$52.9M	$12.4M	+$7.43M	+149%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-13
Q3 2023	$45.4M	$12.7M	-$3.21M	-20.3%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-10-22
Q2 2023	$48.7M	$14.7M	+$2.04M	+16.1%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-07-23
Q1 2023	$46.6M	$13.1M	+$9.12M	+227%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-04-23
Q4 2022	$37.5M	$4.98M	-$912K	-15.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-13
Q3 2022	$38.4M	$15.9M	+$9.7M	+157%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-10-24
Q2 2022	$28.7M	$12.6M	+$9.89M	+359%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-07-25
Q1 2022	$18.8M	$4.01M	-$1.19M	-22.9%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-04-25
Q4 2021	$20M	$5.89M	+$2.05M	+53.5%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-13
Q3 2021	$18M	$6.16M	+$632K	+11.4%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-10-25
Q2 2021	$17.3M	$2.75M	-$3.51M	-56%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-07-26
Q1 2021	$20.8M	$5.2M	-$2.32M	-30.8%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-04-26
Q4 2020	$23.1M	$3.84M	-$2.57M	-40.1%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-14
Q3 2020	$25.7M	$5.53M	+$42K	+0.77%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-10-26
Q2 2020	$25.7M	$6.26M	-$779K	-11.1%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-07-27
Q1 2020	$26.5M	$7.52M	+$2.06M	+37.8%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-04-27
Q4 2019	$24.4M	$6.4M	-$155K	-2.36%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-15
Q3 2019	$24.5M	$5.49M	-$666K	-10.8%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-10-27
Q2 2019	$25.2M	$7.04M	+$2.09M	+42.2%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-28
Q1 2019	$23.1M	$5.46M	+$2.35M	+75.8%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-04-29
Q4 2018	$20.8M	$6.56M	+$4.18M	+175%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-16
Q3 2018	$16.6M	$6.15M	+$838K	+15.8%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-10-29
Q2 2018	$15.8M	$4.95M	+$154K	+3.21%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-30
Q1 2018	$15.6M	$3.11M	-$2.23M	-41.7%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-04-30
Q4 2017	$17.8M	$2.38M	+$2.14M	+865%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-25
Q3 2017	$15.7M	$5.32M	+$2.77M	+109%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-30
Q2 2017	$12.9M	$4.79M	+$1.57M	+48.6%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-07-31
Q1 2017	$11.4M	$5.33M	+$2.82M	+112%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-01
Q4 2016	$8.53M	$247K			Oct 1, 2016	Dec 31, 2016	10-K	2019-02-26
Q3 2016		$2.55M	+$1.91M	+297%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-10-31
Q2 2016		$3.23M			Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-01
Q1 2016		$2.51M			Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-02
Q3 2015		$641K			Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-03

* An asterisk sign (*) next to the value indicates that the value is likely invalid.